July 28, 2021
July 28, 2021 – The U.S. FDA has expanded the scope of Emergency Use Authorization (EUA) for Olumiant
(baricitinib – Eli Lilly) to allow
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Pharmaceutical News
July 28, 2021
July 28, 2021 – Mylan’s Semglee® (insulin glargine-yfgn) injection has been FDA approved as the first
automatically interchangeable insulin and the first automatically interchangeable biosimilar
July 28, 2021
July 28, 2021 – The U.S. FDA has approved two new indications for Merck’s Keytruda (pembrolizumab),
one for endometrial carcinoma and one for triple negative breast cancer (TNBC)
July 27, 2021
July 27, 2021 – The U.S. FDA has approved Twyneo® (tretinoin/benzoyl peroxide) cream, manufactured by Sol-Gel Technologies
July 26, 2021
July 26, 2021 – GlaxoSmithKline's Shingrix® (zoster vaccine recombinant, adjuvanted) has received U.S. FDA approval for an expanded indication
July 23, 2021
July 23, 2021 – The U.S. FDA has approved an expanded indication for Bydureon BCise (exenatide extended release), manufactured by AstraZeneca. Initially FDA approved
July 23, 2021
July 23, 2021 – Bristol Myers Squibb has voluntarily withdrawn an indication for Opdivo® (nivolumab) to be used as a single agent to treat patients who have hepatocellular
July 23, 2021
July 23, 2021 – The U.S. FDA has approved a new indication for Drizalma SprinkleTM (duloxetine) delayed-release oral capsules, manufactured by Sun Pharmaceutical. The capsules are